Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
NTLA
Chart

Intellia Therapeutics, Inc.

NTLA

Jan 1 1970 00:00:00
11.82
▼-0.1500▼-1.25%
12.24
12.37
11.80
11.97
153.23k
-5.23
-2.26
1.22B
103.58M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2024-10-25
Form 8-K
ID: 0001193125-24-244201
2024-10-04
Form 4
ID: 0000950170-24-112980
2024-08-08
Form 10-Q
ID: 0000950170-24-093907
2024-08-08
Form 8-K
ID: 0000950170-24-093339
2024-07-24
Form 4
ID: 0000950170-24-086061
2024-07-24
Form 3
ID: 0000950170-24-086046
2024-07-18
Form S-8
ID: 0001193125-24-181015
2024-07-03
Form 4
ID: 0000950170-24-081259
2024-07-03
Form 4
ID: 0000950170-24-081258
2024-06-26
Form 8-K
ID: 0001193125-24-168545

You might find these companies interesting

BMRA
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances (2835)
NYMXF
Nymox Pharmaceutical Corp
In Vitro & In Vivo Diagnostic Substances (2835)
TNFA
Tnf Pharmaceuticals, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
CLDX
Celldex Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
TKNO
Alpha Teknova, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
BZYR
Burzynski Research Institute Inc
In Vitro & In Vivo Diagnostic Substances (2835)
OCX
Oncocyte Corp
In Vitro & In Vivo Diagnostic Substances (2835)
ABIO
Arca Biopharma, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
QDEL
Quidelortho Corp
In Vitro & In Vivo Diagnostic Substances (2835)
ICCC
Immucell Corp /De/
In Vitro & In Vivo Diagnostic Substances (2835)
NAVB
Navidea Biopharmaceuticals, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
VRAX
Virax Biolabs Group Ltd
In Vitro & In Vivo Diagnostic Substances (2835)
VIR
Vir Biotechnology, Inc.
Biological Products, (No Diagnostic Substances) (2836)
CERE
Cerevel Therapeutics Holdings, Inc.
Pharmaceutical Preparations (2834)